$7.7
0.78%
Downside
Day's Volatility :4.26%
Upside
3.51%
29.61%
Downside
52 Weeks Volatility :52.5%
Upside
32.52%
Period | Health Catalyst Inc | |
---|---|---|
3 Months | 27.91% | |
6 Months | 18.83% | |
1 Year | 1.32% | |
3 Years | -85.59% |
Market Capitalization | 469.9M |
Book Value | $5.94 |
Earnings Per Share (EPS) | -1.49 |
Wall Street Target Price | 11.3 |
Profit Margin | -28.87% |
Operating Margin TTM | -15.94% |
Return On Assets TTM | -6.58% |
Return On Equity TTM | -23.15% |
Revenue TTM | 299.5M |
Revenue Per Share TTM | 5.16 |
Quarterly Revenue Growth YOY | 3.6999999999999997% |
Gross Profit TTM | 135.6M |
EBITDA | -41.7M |
Diluted Eps TTM | -1.49 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.36 |
EPS Estimate Next Year | 0.48 |
EPS Estimate Current Quarter | 0.08 |
EPS Estimate Next Quarter | 0.1 |
What analysts predicted
Upside of 46.75%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 112.6M | ↑ 54.04% |
Net Income | -62.0M | ↑ 31.78% |
Net Profit Margin | -55.06% | ↑ 9.3% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 154.9M | ↑ 37.63% |
Net Income | -60.1M | ↓ 3.05% |
Net Profit Margin | -38.79% | ↑ 16.27% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 188.8M | ↑ 21.88% |
Net Income | -115.0M | ↑ 91.39% |
Net Profit Margin | -60.91% | ↓ 22.12% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 241.9M | ↑ 28.11% |
Net Income | -153.2M | ↑ 33.21% |
Net Profit Margin | -63.33% | ↓ 2.42% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 276.2M | ↑ 14.18% |
Net Income | -137.4M | ↓ 10.32% |
Net Profit Margin | -49.74% | ↑ 13.59% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 295.9M | ↑ 7.13% |
Net Income | -118.1M | ↓ 14.01% |
Net Profit Margin | -39.92% | ↑ 9.82% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 73.9M | ↑ 6.8% |
Net Income | -33.2M | ↓ 7.24% |
Net Profit Margin | -44.93% | ↑ 6.81% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 73.2M | ↓ 0.89% |
Net Income | -32.6M | ↓ 1.74% |
Net Profit Margin | -44.55% | ↑ 0.38% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 73.8M | ↑ 0.76% |
Net Income | -22.0M | ↓ 32.44% |
Net Profit Margin | -29.86% | ↑ 14.69% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 75.1M | ↑ 1.78% |
Net Income | -30.3M | ↑ 37.58% |
Net Profit Margin | -40.37% | ↓ 10.51% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 74.7M | ↓ 0.48% |
Net Income | -20.6M | ↓ 32.08% |
Net Profit Margin | -27.55% | ↑ 12.82% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 75.9M | ↑ 1.58% |
Net Income | -13.5M | ↓ 34.35% |
Net Profit Margin | -17.81% | ↑ 9.74% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 111.0M | ↑ 0.64% |
Total Liabilities | 485.7M | ↑ 31.37% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 302.4M | ↑ 172.46% |
Total Liabilities | 101.7M | ↓ 79.06% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 577.7M | ↑ 91.08% |
Total Liabilities | 301.6M | ↑ 196.55% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 832.1M | ↑ 44.03% |
Total Liabilities | 310.0M | ↑ 2.77% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 752.3M | ↓ 9.59% |
Total Liabilities | 327.3M | ↑ 5.57% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 701.8M | ↓ 6.71% |
Total Liabilities | 334.9M | ↑ 2.33% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 752.3M | ↑ 0.0% |
Total Liabilities | 347.2M | ↑ 6.07% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 722.9M | ↓ 3.91% |
Total Liabilities | 333.0M | ↓ 4.07% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 712.9M | ↓ 1.38% |
Total Liabilities | 330.5M | ↓ 0.75% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 701.8M | ↓ 1.56% |
Total Liabilities | 334.9M | ↑ 1.32% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 695.1M | ↓ 0.95% |
Total Liabilities | 337.9M | ↑ 0.9% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 691.7M | ↓ 0.49% |
Total Liabilities | 334.7M | ↓ 0.94% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -40.3M | ↑ 9.41% |
Investing Cash Flow | 21.4M | ↓ 4.49% |
Financing Cash Flow | 24.3M | ↓ 2.11% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -32.2M | ↓ 20.13% |
Investing Cash Flow | -209.6M | ↓ 1079.31% |
Financing Cash Flow | 231.4M | ↑ 850.39% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -26.1M | ↓ 18.75% |
Investing Cash Flow | -82.6M | ↓ 60.61% |
Financing Cash Flow | 182.6M | ↓ 21.08% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -23.1M | ↓ 11.57% |
Investing Cash Flow | -139.7M | ↑ 69.17% |
Financing Cash Flow | 264.1M | ↑ 44.62% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -35.3M | ↑ 52.53% |
Investing Cash Flow | -39.0M | ↓ 72.06% |
Financing Cash Flow | -2.6M | ↓ 100.99% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -5.6M | ↓ 62.35% |
Investing Cash Flow | 22.6M | ↑ 262.04% |
Financing Cash Flow | 93.0K | ↓ 85.4% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -11.6M | ↑ 107.42% |
Investing Cash Flow | -7.4M | ↓ 132.74% |
Financing Cash Flow | 1.2M | ↑ 1192.47% |
Sell
Neutral
Buy
Health Catalyst Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Health Catalyst Inc | 0.92% | 18.83% | 1.32% | -85.59% | -76.86% |
Solventum Corp | 7.73% | 12.08% | 4.86% | 4.86% | 4.86% |
Tempus Ai | -5.92% | 14.43% | 14.43% | 14.43% | 14.43% |
Veeva Systems Inc. | 4.03% | 4.59% | 9.35% | -33.12% | 46.51% |
Ge Healthcare Technologies Inc. | -3.26% | 9.41% | 21.49% | 43.74% | 43.74% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Health Catalyst Inc | NA | NA | NA | 0.36 | -0.23 | -0.07 | NA | 5.94 |
Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
Tempus Ai | NA | NA | NA | -2.41 | 0.0 | 0.0 | NA | 0.64 |
Veeva Systems Inc. | 56.89 | 56.89 | 1.22 | 4.76 | 0.13 | 0.06 | NA | 32.04 |
Ge Healthcare Technologies Inc. | 23.93 | 23.93 | 2.29 | 4.28 | 0.22 | 0.06 | 0.0 | 18.2 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Health Catalyst Inc | Buy | $469.9M | -76.86% | NA | -28.87% |
Solventum Corp | Hold | $10.8B | 4.86% | NA | 15.73% |
Tempus Ai | NA | $7.9B | 14.43% | NA | -121.04% |
Veeva Systems Inc. | Buy | $34.5B | 46.51% | 56.89 | 23.91% |
Ge Healthcare Technologies Inc. | Buy | $39.9B | 43.74% | 23.93 | 8.56% |
BlackRock Inc
Vanguard Group Inc
First Light Asset Management, LLC
Millennium Management LLC
PRIMECAP Management Company
Daventry Group, LP
health catalyst is dedicated to enabling health care organizations to fundamentally improve care by building the most comprehensive and fully integrated suite of healthcare data warehousing and process improvement solutions available. health catalyst was formed by a group of healthcare veterans with vast data warehousing and quality improvement experience. our founders and executives collaborated for nearly a decade to revolutionize clinical process models using analytics. during development, they faced numerous hurdles in the quest to develop a data warehouse that could handle the complexities unique to healthcare data. after determining that the predominant approaches to data modeling weren’t effective for healthcare data, they discovered the solution, which is now known as the adaptive data architecture. using a late-binding bus architecture, catalyst’s adaptive data model is agile, flexible, and can be implemented in a matter of weeks compared to the months or years traditional app
Organization | Health Catalyst Inc |
Employees | 1300 |
CEO | Mr. Daniel D. Burton |
Industry | Technology Services |
Victoryshares International
$7.70
-0.9%
Clearbridge Focus Value Esg Etf
$7.70
-0.9%
Cabana Target Drawdwn 10 Etf
$7.70
-0.9%
Spdr Nyse Technology Etf
$7.70
-0.9%
Global Ship Lease Inc-cl A
$7.70
-0.9%
Standard Motor Products Inc
$7.70
-0.9%
Cp High Yield Trend Etf
$7.70
-0.9%
Gain Therapeutics Inc
$7.70
-0.9%
Olaplex Holdings, Inc.
$7.70
-0.9%